Coca-Cola clarified that Coke Zero and Diet Coke do not contain the sugar replacement called erythritol but instead have aspartame.
According to Coca-Cola’s official website, aspartame is used in some of its products including Coke Zero Sugar, Diet Coke, Diet Coke Feisty Cherry, Diet Barq’s, Fanta Zero, Fresca, Gold Peak Diet Tea, Mello Yello Zero, Minute Maid Light, Pibb Zero, Seagrams Ginger Ale Zero Sugar, and Sprite Zero.
Aspartame provides low or no sugar calories option.
Unlike erythritol, aspartame hasn’t been linked with any serious side effects or health problems.
A recent study draws attention to the harmful effects of erythritol such as linked to causing serious health issues, including the risk of stroke, blood clotting, and heart attack
Erythritol reportedly used to “add bulk or sweeten monk fruit and keto reduced-sugar products.
According to Peace Health, one of the names for sugar alcohols used in foods labeled "sugar-free" or "no sugar added" is erythritol.
It is regarded as having calories and carbohydrates even if it is labeled as "sugar-free". It is said to have negative effects on persons who already have other underlying medical issues because it can raise blood sugar levels.
Erythritol is found naturally in some foods like wine, beer, and even cheese when they ferment.


RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
UK Consumer Confidence Weakens Amid Middle East Conflict and Rising Living Costs
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Why financial hardship is more likely if you’re disabled or sick
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 



